EQT

EQT is a global private equity firm founded in 1994 that invests in mid-market companies through buyouts, expansion capital, growth equity, and infrastructure opportunities. It targets opportunities in Europe, North America, and Asia across sectors such as healthcare, life sciences, technology, industrials, consumer services, and real estate, seeking durable cash flows and meaningful intrinsic value. EQT pursues controlling or co-controlling stakes and collaborates with management to drive growth, improve operations, and expand internationally. The firm maintains a broad geographic footprint and an ownership orientation designed to build market-leading companies with sustainable competitive advantages. By combining sector expertise with disciplined capital allocation, EQT aims to create long-term value for its portfolio and stakeholders while adapting to evolving market dynamics.

Sofia Ahuja

Partner

Christian Andersen

Managing Director, Private Equity and Investment Advisory Professional

James Arrol

Managing Director, Fund Management

Teruyuki Asaoka

Managing Director

Fouad Azzam

Partner

Fredrik Backman

Managing Director, Client Relations

Peter Balslev

Managing Director

Johann-Christoph Balzer

Partner

Eirik Benzon

Managing Director

William Bergström

Director

Lennart Blecher

Partner, Deputy Managing Partner and Head of EQT Infrastructure

Mark Braganza

Partner, Investment Advisory

Marcus Brennecke

Partner and Co-Head of EQT Equity advisory team

Carolina Brochado

Partner at EQT

Christoph Broja

Managing Director

Marc Brown JD

Partner and Head of EQT Growth

Anna Brundtland

Managing Director

Philipp Bräuer

Associate

Drew Burdon

Partner

Brian Chang

Partner

Kenneth Cheong

Partner

Wonho Choi

Vice President

Henry Connon

Associate, Private Equity and Investment Advisory Professional

Crosby Cook

Partner, Infrastructure and Investment Advisory Professional

Guy Cui Ph.D

Partner

Nicholas Curwen

Managing Director

Alex Darden

Partner, President and Head of EQT Infrastructure Advisory Team Americas at EQT X

Isabel De Paoli

Partner, Healthcare

Rudy Dekeyser Ph.D

Partner

Johan Dettel

Partner

Asis Echaniz

Partner and Head of Spain

Andreas Eichelberger

Director

Frederik Elwing

Managing Director

Victor Englesson

Partner

Stephen Escudier

Partner, Credit, New York

Frank Feng

Managing Director

Andreas Fischer

Partner

Mark Fogle

Partner and Head of EQT Exeter APAC

David Forde

Partner

Per Franzen

Head of Private Capital and Deputy Managing Partner

Juho Frilander

Managing Director

Florian Funk

Partner, Private Equity

Guillermo Garcia-Barrero

Managing Director, Infrastructure

Carlos Garcia-Fuster

Partner

Henrik Giver

Managing Director

Simon Gold

Managing Director, Client Relations and Capital Raising

Hari Gopalakrishnan

Partner and Global Co-Head of Services, Private Capital

Wolfgang Gorny

Partner, Private Equity

Alexander Greenbaum

Partner

Fabian Grone

Partner, Head of Asia

Carl-Magnus Hallberg

Managing Director

Kevin Hammon

Associate

Frank Heckes

Partner, Private Equity

Erika Henriksson

Partner, Private Equity

Jak Hestnes

Managing Director and Board Member

Gerran Ho

Managing Director, Mid Market Asia

Christian Horn

Managing Director

Andreas Huber

Partner

Sara Huda

Managing Director and Head of Investment Services

Johan Hylander

Managing Director

Bert Janssens

Partner

Patrick Jaslowitzer

Managing Director

Neha Jatar

Managing Director

Yan Jiao

Partner

Herman Johre

Associate

Nathalie Kaeser

Vice President, Private Equity

Kosmo Kalliarekos

Partner

Viviana Kane

Managing Director

Masahiko Kato

Managing Director and Head of Infrastructure Japan

Matthew Kestenbaum

Managing Director

Nils Ketter

Partner

Paul Kim

Managing Director

Jörg Kinberger

Partner

Cillian King

Managing Director

Kasper Knokgaard

Partner

Vesa Koskinen

Partner, Private Equity and Head of Finland

Gleb Kozyritskiy

Managing Director

René Kuijten Ph.D

Partner

Arvindh Kumar

Partner and Co-Head of Technology Sector Team

Tobias Kung

Managing Director, Infrastructure

Elias Källström

Managing Director

Ulrich Kollensperger

Partner

Priscilla Lam

Managing Director, Portfolio Monitoring

Lance Lan

Managing Director, Exit Management

Adam Larsson

Managing Director

Kenneth Lau

Associate

Edward Lavish

Managing Director, Portfolio Risk and Transactions

Juliette Lee

Associate

Alex Lee

Partner

Eu Han Lee

Partner, Debt Capital Markets

Hong Yong Leong

Partner

Janice Leow

Partner

William Liang

Director of European Firm

Benjamin Lim

Director

William Lindström

Managing Director

Gebhard Littich

Managing Director

Eric Liu

Partner, Head of North American Private Equity and Co-Head of the Global Healthcare Sector Team

Nicholas Macksey

Partner

Robert Maclean

Partner

Madeleine Magnerius

Vice President

Paola Maleh

Partner and Head of EMEA

Francesco Malvezzi

Managing Director, Infrastructure

Tadashi Maruoka

Partner

Axel Masucci

Managing Director

Arnav Mitra

Director

Martin Mix

Managing Director

Mikael Moll

Managing Director, Public Value

Maximilian Moser

Associate

Joep Muijrers Ph.D

General Partner

Pascal Noel

Managing Director

Tetsuro Onitsuka

Partner and Head of Private Equity Japan

John Österlund

Managing Director

Alex Paganini

Associate

Sydney Pardey

Managing Director

Tyler Parker

Managing Director, Private Equity Technology Team

Daniel Perez

Partner

Christopher Popp

Managing Director

Anne Portwich

Partner

Shane Predeek

Partner

Federico Quitadamo

Partner and Head of Italy

Vai Rajan

Head of EMEA Private Wealth Capital Raising and Director - Client Relations and Capital Raising

Thomas Rajzbaum

Managing Director and Partner, EQT Infrastructure

Hermann Rauch

Managing Director

Vera Rebanova

Partner

Johannes Reichel

Partner

Carl Johan

Partner

Matthias Riefer

Managing Director, Private Equity

Niklas Ringby

Partner

Patrick Rodden

Managing Director and Head of Infrastructure for Australia and New Zealand

Maxwell Roitstein

Associate

Joachim Rothe

Partner

Isidoor Rutten

Partner and Head of Private Equity Benelux

Rob Ryan

Managing Director, Market Risk

Darlene Sammon

Partner

Mika Saukkonen

Managing Director, Infrastructure

Matthew Scattarella

Partner

Philip Scheltens

Partner

Nirav Shah

Partner

Hemant Sharma

Managing Director

Christian Sinding

CEO, Managing Partner, Member of Executive Committee

Piyush Singhvi

Managing Director, Infrastructure

Carl Sjölund

Partner, Infrastructure

Jared Small

Managing Director

Georg Stadler

Partner, Infrastructure

Dominik Stein

Partner and Head of EQT Growth Advisory Team

Joshua Stone

Managing Director, FO Head of Strategic Initiatives

Alexander Strassburger

Managing Director

Marc-Alexander Straubinger

Managing Director

Jan Stypulkowski

Managing Director

Sang Jun Suh

Partner

Anna Sundell

Partner, Infrastructure

Miriam Tawil

Partner and Investment Advisory Professional

Michiel Thiessen

Managing Director

Elly Thio

Managing Director

Erwin Thompson

Partner, Infrastructure

Matteo Thun

Partner

Simon Tillmo

Director, Private Equity

Andrew Tirbeni

Managing Director, EQT Client Relations and Capital Raising

Wei Tor

Managing Director

Juan Vargas

Partner, Infrastructure at EQT

Felice Verduyn - van Weegen

Partner

Jan Vesely

Partner at EQT

Marcus Wallinder

Partner and Deputy Head of Client Relations and Capital Raising

Forrest Wang

Managing Director, Private Equity

Ethan Waxman

Partner

Rickard Wilson

Managing Director

Matthias Wittkowski

Partner

Ken Wong

Partner and Head of Asia Pacific, Infrastructure

Philipp Worner

Director, Private Equity

Dayea Yeon

Managing Director and Head of Private Capital Korea

Shuting You

Managing Director

James Yu

Partner and Senior Bank Relationship Manager

Julia Zhu

Managing Director

Zoe Zhu

Director

Maarten de Jong

Partner

John de Koning

Partner

Arno de Wilde

Investor

Clemens van Blitterswijk

Venture Partner

Floris van Halder

Managing Director, Private Equity

Fredrik Atting

Partner

Past deals in Ireland

Perfuze

Venture Round in 2025
Founded in 2018, Perfuze is a medical device company based in Galway, Ireland. It specializes in developing catheter-based aspiration technology designed to treat acute ischemic stroke efficiently and effectively.

NUA Surgical

Series A in 2024
NUA Surgical is an award-winning company based in Galway, Ireland, developing and manufacturing surgical instruments for obstetrics and gynecology. Its patented disposable C-section retractor is designed to improve ergonomics and safety during caesarean deliveries, aiming to reduce complications and support safer care for mothers and infants.

AMCS Group

Acquisition in 2024
AMCS Group is an Irish company specializing in integrated software and technology solutions for the waste, recycling, and resource management industries. Established in 2002 by James Martin and Austin Ryan, AMCS offers a range of products including weighing and RFID technology, mobile computing solutions, and ERP software designed to optimize business processes and improve customer service.

Keywords Studios

Acquisition in 2024
Keywords Studios is a prominent provider of technological assistance to the video gaming industry, offering a wide range of specialized services that support various aspects of game development. The company operates through three primary service segments: Create, Globalize, and Engage. Its offerings include game localization, testing, art creation, audio production, and more, effectively enhancing the quality and reach of games. Keywords Studios collaborates with numerous game developers and publishers across the globe, with a presence in countries such as Ireland, the United States, the United Kingdom, Canada, Switzerland, Japan, Italy, France, and India. Through its comprehensive solutions, Keywords Studios plays a crucial role in the game development lifecycle.

Perfuze

Series A in 2022
Founded in 2018, Perfuze is a medical device company based in Galway, Ireland. It specializes in developing catheter-based aspiration technology designed to treat acute ischemic stroke efficiently and effectively.

Neurent Medical

Series B in 2021
Founded in 2015, Neurent Medical is a medical device company based in Galway, Ireland. It specializes in developing non-surgical treatments for chronic rhinitis using minimally invasive, hand-held radio-frequency devices.

Cybin

Series B in 2020
Cybin is a biopharmaceutical company dedicated to advancing research and development in psychedelic and medicinal mushrooms. It focuses on creating safe and effective therapeutics for mental health issues, with an emphasis on psilocybin-based products. The company is actively launching these products in jurisdictions where they are permitted and is engaged in clinical studies across North America and other regions. Through strategic partnerships with academic and institutional entities, Cybin seeks to develop novel compounds and delivery mechanisms, aiming to provide innovative treatments for various psychiatric and neurological conditions.

Atlantic Therapeutics Limited

Series B in 2019
Atlantic Therapeutics Limited is a medical technology company based in Galway, Ireland, with additional offices in London, Paris, and Salem. Established in 2013, the company specializes in the manufacture and distribution of medical devices designed for pelvic floor muscle strengthening and nerve stimulation. Its key products include Innovotherapy, a device aimed at enhancing pelvic floor muscle function, and INNOVO, a wearable device specifically targeting stress urinary incontinence by addressing its underlying causes. Atlantic Therapeutics distributes its products through a network of distributors across Ireland, the United Kingdom, France, Germany, and the Middle East. The company operates as a subsidiary of Bio-Medical Research Limited.

Dojo

Debt Financing in 2018
Dojo is a financial technology company that specializes in providing card payment solutions to small and medium-sized businesses in the UK and Ireland. The company offers a range of services, including contactless card machines, online payment systems, and integrated solutions, allowing over 100,000 businesses to accept payments in-store, online, via phone, and on the move. Founded in 2008 and based in London, Dojo focuses on delivering flexible and efficient payment processing options tailored to the needs of its clients. The company's offerings aim to enhance the payment experience for both merchants and their customers, thereby facilitating smoother transactions across various platforms.

Dojo

Debt Financing in 2016
Dojo is a financial technology company that specializes in providing card payment solutions to small and medium-sized businesses in the UK and Ireland. The company offers a range of services, including contactless card machines, online payment systems, and integrated solutions, allowing over 100,000 businesses to accept payments in-store, online, via phone, and on the move. Founded in 2008 and based in London, Dojo focuses on delivering flexible and efficient payment processing options tailored to the needs of its clients. The company's offerings aim to enhance the payment experience for both merchants and their customers, thereby facilitating smoother transactions across various platforms.

Vivasure Medical

Series C in 2016
Vivasure Medical Limited is a medical device company based in Galway, Ireland, that specializes in the research, development, and manufacture of arterial and venous closure devices utilizing its patented PerQseal technology. The company focuses on creating polymer implants and delivery systems aimed at minimally invasive vessel closures, primarily in cardiology, interventional radiology, and vascular surgery. Its flagship product is an absorbable patch-based large-bore percutaneous closure device, designed to effectively close large arteriotomies resulting from transcatheter procedures, including transcatheter aortic valve replacement and endovascular aneurysm repair. Founded in 2008, Vivasure Medical is committed to advancing techniques that enhance patient outcomes in vascular access procedures.

Neuravi

Series B in 2015
Neuravi Limited, established in 2009 and based in Galway, Ireland, specializes in designing and developing medical devices for treating acute ischemic strokes. The company's primary product, the EmboTrap revascularization device, is designed to restore blood flow by removing clots from blocked brain arteries. Neuravi operates in multiple European countries and is a subsidiary of DePuy Ireland Unlimited Company.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.